AAPG vs VRTX: Which Stock is Better?
Side-by-side comparison of Ascentage Pharma Group International and Vertex Pharmaceuticals Inc in 2026
AAPG
Ascentage Pharma Group International
$26.01
VRTX
Vertex Pharmaceuticals Inc
$442.08
Key Metrics Comparison
| Metric | AAPG | VRTX | Winner |
|---|---|---|---|
| Market Cap | $2.53B | $113.35B | VRTX |
| P/E Ratio | N/A | 31.15 | VRTX |
| EPS (TTM) | $N/A | $14.19 | VRTX |
| Revenue Growth | -0.7% | 0.1% | VRTX |
| Gross Margin | 90.9% | 52.7% | AAPG |
Analyze AAPG
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AAPG or VRTX a better investment?
Comparing AAPG and VRTX: Ascentage Pharma Group International has a market cap of $2.53B while Vertex Pharmaceuticals Inc has $113.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AAPG and VRTX?
AAPG (Ascentage Pharma Group International) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AAPG or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AAPG or VRTX?
VRTX has higher revenue growth at 0.1% vs -0.7% for AAPG.
Which company is more profitable: AAPG or VRTX?
Ascentage Pharma Group International (AAPG) has higher gross margins at 90.9% compared to 52.7% for VRTX.
Which is the larger company: AAPG or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $113.35B compared to $2.53B for AAPG.
Should I buy AAPG or VRTX in 2026?
Both AAPG and VRTX have investment merit. AAPG trades at $26.01 while VRTX trades at $442.08. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AAPG and VRTX stock?
Key differences: Market Cap ($2.53B vs $113.35B), P/E Ratio (N/A vs 31.2x), Revenue Growth (-0.7% vs 0.1%), Gross Margin (90.9% vs 52.7%).